Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Eribulin -- a review of preclinical and clinical studies.
Swami U, Chaudhary I, Ghalib MH, Goel S. Swami U, et al. Among authors: ghalib mh. Crit Rev Oncol Hematol. 2012 Feb;81(2):163-84. doi: 10.1016/j.critrevonc.2011.03.002. Epub 2011 Apr 14. Crit Rev Oncol Hematol. 2012. PMID: 21493087 Free PMC article. Review.
Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors.
Gollamudi R, Ghalib MH, Desai KK, Chaudhary I, Wong B, Einstein M, Coffey M, Gill GM, Mettinger K, Mariadason JM, Mani S, Goel S. Gollamudi R, et al. Among authors: ghalib mh. Invest New Drugs. 2010 Oct;28(5):641-9. doi: 10.1007/s10637-009-9279-8. Epub 2009 Jul 2. Invest New Drugs. 2010. PMID: 19572105 Free PMC article. Clinical Trial.
Reovirus: a targeted therapeutic--progress and potential.
Maitra R, Ghalib MH, Goel S. Maitra R, et al. Among authors: ghalib mh. Mol Cancer Res. 2012 Dec;10(12):1514-25. doi: 10.1158/1541-7786.MCR-12-0157. Epub 2012 Oct 4. Mol Cancer Res. 2012. PMID: 23038811 Free PMC article. Review.
A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors.
Ghamande S, Lin CC, Cho DC, Shapiro GI, Kwak EL, Silverman MH, Tseng Y, Kuo MW, Mach WB, Hsu SC, Coleman T, Yang JC, Cheng AL, Ghalib MH, Chuadhary I, Goel S. Ghamande S, et al. Among authors: ghalib mh. Invest New Drugs. 2014 Jun;32(3):445-51. doi: 10.1007/s10637-013-0044-7. Epub 2013 Nov 24. Invest New Drugs. 2014. PMID: 24271274 Clinical Trial.
Comparative Effectiveness Research: The Impact of Biologic Agents in Ethnic Minorities With Metastatic Colorectal Cancer.
Goel S, Negassa A, Khot A, Goyal D, Guo S, Nandikolla A, Bakirhan K, Polineni R, Shah U, Chaudhary I, Ghalib MH, Rajdev L, Kaubisch A, Chuy J, Aparo S. Goel S, et al. Among authors: ghalib mh. Clin Colorectal Cancer. 2017 Dec;16(4):286-292. doi: 10.1016/j.clcc.2017.03.004. Epub 2017 Mar 14. Clin Colorectal Cancer. 2017. PMID: 28412139
12 results